Volumen | 388.503 |
|
|||||
News | - | ||||||
Tageshoch | 7,70 | Niedrig Hoch |
|||||
Tagestief | 6,86 |
Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Larimar Therapeutics Inc | LRMR | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
6,86 | 6,86 | 7,70 | 7,35 | 6,89 |
Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
---|---|---|---|---|---|
5.851 | 388.503 | US$ 7,36 | US$ 2.861.020 | - | 2,18 - 13,68 |
Letzte Trade | Typ | Menge | Kurs | Währung |
---|---|---|---|---|
22:20:05 | formt | 120 | US$ 7,35 | USD |
Finanzwerte LRMR
Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
---|---|---|---|---|---|---|
63,16M | 63,80M | - | 0 | -36,95M | -0,58 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Larimar Therapeutics
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
11.3.2024 | 21:09 | Edgar (US Regulatory) | Form 8-K - Current report |
16.2.2024 | 22:06 | Edgar (US Regulatory) | Form 8-K - Current report |
15.2.2024 | 02:57 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
14.2.2024 | 23:08 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
14.2.2024 | 14:55 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
14.2.2024 | 12:06 | Edgar (US Regulatory) | Form 8-K - Current report |
13.2.2024 | 22:46 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
12.2.2024 | 13:03 | Edgar (US Regulatory) | Form 8-K - Current report |
19.1.2024 | 22:33 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
19.1.2024 | 22:32 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
19.1.2024 | 22:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
19.1.2024 | 22:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
Forum Larimar Therapeutics
Keine Diskussionen Gefunden.Neuen Thread Erstellen
LRMR Historisch
Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
---|---|---|---|---|---|---|---|
1 Woche | 6,48 | 7,70 | 5,91 | 6,56 | 244.589 | 0,87 | 13,43% |
1 Monat | 7,89 | 8,056 | 5,91 | 6,96 | 338.738 | -0,54 | -6,84% |
3 Monate | 6,20 | 13,68 | 5,70 | 9,69 | 678.550 | 1,15 | 18,55% |
6 Monate | 2,90 | 13,68 | 2,18 | 8,65 | 395.681 | 4,45 | 153,45% |
1 Jahr | 4,96 | 13,68 | 2,18 | 6,75 | 318.289 | 2,39 | 48,19% |
3 Jahre | 13,32 | 15,49 | 1,53 | 6,18 | 209.814 | -5,97 | -44,82% |
5 Jahre | 12,00 | 25,87 | 1,53 | 6,92 | 171.249 | -4,65 | -38,75% |